[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337986-105":59,"doc-detail-337986-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","use-of-drug-sensitisers-to-improve-therapeutic-index-in-cancer","Use of Drug Sensitisers to Improve Therapeutic Index in Cancer","","Clinical management of malignant tumours is difficult, often resulting in severe adverse effects and death. Drug resistance undermines treatment effectiveness, and simply increasing drug dosage can worsen the therapeutic index. Drug sensitizers—chemical agents that enhance pharmacokinetics, modulate cellular pathways, and regulate membrane transporters—can enable effective dosing at the disease site, helping delay resistance and reduce side effects. This review summarizes TI’s role, notes the lack of unified TI standards, reviews benefit–risk criteria, discusses TI use in industry, and presents a binary weapon approach to improve dose-toxicity ratios.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/use-of-drug-sensitisers-to-improve-therapeutic-index-in-cancer/337986/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/use-of-drug-sensitisers-to-improve-therapeutic-index-in-cancer/337986.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is therapeutic index (TI) important in cancer drug development?","Question",{"text":112,"@type":113},"TI helps evaluate the balance between effective drug dosing and toxic dose exposure. It is used to judge safety and efficacy while managing risks during development.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What are drug sensitizers and how do they improve TI?",{"text":117,"@type":113},"Drug sensitizers enhance pharmacokinetics, target cellular pathways, and regulate membrane transporters. They support achieving effective treatment doses at the disease site, which can limit side effects and reduce drug–drug interactions by lowering required drug doses.",{"name":119,"@type":110,"acceptedAnswer":120},"What challenges exist in standardizing TI within the pharmaceutical field?",{"text":121,"@type":113},"The review states there is no unified standard for TI in the field. It highlights the need for criteria to systematically evaluate drug safety and efficiency for practical implementation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337986,1790230711,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","pharmaceutics  \nReview  \nUse of Drug Sensitisers to Improve Therapeutic Index in Cancer  \nYu-Shan Chen 1,†, Enhui Jin 1,† and Philip J. Day 1,2, *  \nCitation: Chen, Y.-S.; Jin, E.; Day, P.J. Use of Drug Sensitisers to Improve Therapeutic Index in Cancer. Pharmaceutics 2024, 16, 928 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)pharmaceutics16070928  \nAcademic Editors: Keumhan Nohand Jong Hwa Lee  \nReceived: 30 May 2024  \nRevised: 4 July 2024  \nAccepted: 9 July 2024  \nPublished: 11 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Division of Evolution, Infection and Genomics, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK; [yu-shan.chen@postgrad.manchester.ac.uk](yu-shan.chen@postgrad.manchester.ac.uk) (Y.-S.C.); [enhui.jin@postgrad.manchester.ac.uk](enhui.jin@postgrad.manchester.ac.uk) (E.J.)  \n2 Department of Medicine, University of Cape Town, Cape Town 7925, South Africa  \n* [Correspondence: philip.j.day@manchester.ac.uk](Correspondence: philip.j.day@manchester.ac.uk)  \n† These authors contributed equally to this work.  \nAbstract: The clinical management of malignant tumours is challenging, often leading to severe adverse effects and death. Drug resistance (DR) antagonises the effectiveness of treatments, and increasing drug dosage can worsen the therapeutic index (TI) . Current efforts to overcome DR predominantly involve the use of drug combinations, including applying multiple anti-cancerous drugs, employing drug sensitisers, which are chemical agents that enhance pharmacokinetics (PK), including the targeting of cellular pathways and regulating pertinent membrane transporters. While combining multiple compounds may lead to drug–drug interactions (DDI) or polypharmacy effect, the use of drug sensitisers permits rapid attainment of effective treatment dosages at the disease site to prevent early DR and minimise side effects and will reduce the chance of DDI as lower drug doses are required. This review highlights the essential use of TI in evaluating drug dosage for cancer treatment and discusses the lack of a unified standard for TI within the field. Commonly used benefit–risk assessment criteria are summarised, and the critical exploration of the current use of TI in the pharmaceutical industrial sector is included. Specifically, this review leads to the discussion of drug sensitisers to facilitate improved ratios of effective dose to toxic dose directly in humans. The combination of drug and sensitiser molecules might see additional benefits to rekindle those drugs that failed late-stage clinical trials by the removal of detrimental off-target activities through the use of lower drug doses. Drug combinations and employing drug sensitisers are potential means to combat DR. The evolution of drug combinations and polypharmacy on TI are reviewed. Notably, the novel binary weapon approach is introduced as a new opportunity to improve TI. This review emphasises the urgent need for a criterion to systematically evaluate drug safety and efficiency for practical implementation in the field.  \nKeywords: therapeutic index; cancer; drug interaction; drug combination; polypharmacy; drugsensitisers; binary weapon; precision medicine  \n1. Therapeutic Index and Its Use in the Pharmaceutical Sector  \nThe pharmaceutical sector continues to face significant challenges in drug development. Approximately 90% of drug candidates do not achieve approval, especially failing during clinical trial stages III and IV, which is primarily attributed to insufficient clinical efficacy (40–50%), excessive toxicity (30%), unfavourable drug properties (1","cbCaipgjLbCmmqNS","https://ap.wps.com/l/cbCaipgjLbCmmqNS","pdf",1714110,21,"English","# Therapeutic Index and Its Use in the Pharmaceutical Sector\n## Challenges in Drug Development and Approval\n## Benefit–Risk Frameworks and Quantitative Assessment\n## Role of Therapeutic Index (TI) in Safety and Efficacy","[{\"question\":\"Why is therapeutic index (TI) important in cancer drug development?\",\"answer\":\"TI helps evaluate the balance between effective drug dosing and toxic dose exposure. It is used to judge safety and efficacy while managing risks during development.\"},{\"question\":\"What are drug sensitizers and how do they improve TI?\",\"answer\":\"Drug sensitizers enhance pharmacokinetics, target cellular pathways, and regulate membrane transporters. They support achieving effective treatment doses at the disease site, which can limit side effects and reduce drug–drug interactions by lowering required drug doses.\"},{\"question\":\"What challenges exist in standardizing TI within the pharmaceutical field?\",\"answer\":\"The review states there is no unified standard for TI in the field. It highlights the need for criteria to systematically evaluate drug safety and efficiency for practical implementation.\"}]","Use of Drug Sensitisers to Improve Therapeutic Index in Cancer | PDF",1790021435,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c498e84a941362f912ce2adee023bd6.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6ba14b3ec25c52080af449ca855d7f19.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f83cfe321c8d32b04ab61d713e7989ac.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8c2601ccb4f2690a3739bb8a731e9667.webp",980,1385]